T. Rowe Price Associates »

Definium Therape shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Definium Therape (DFTX) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Definium Therape

Tip: Access up to 7 years of quarterly data

All positions including Definium Therape held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Definium Therape by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.3M 70k 18.91
2025-12-31 $700k 52k 13.40

More positions owned by T. Rowe Price Associates

Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Microsoft Corp Comm Stk (MSFT)
Broadcom Comm Stk (AVGO)
Amazon Comm Stk (AMZN)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Jpmorgan Chase & Co Comm Stk (JPM)
Ge Aerospace Comm Stk (GE)

View all positions for T. Rowe Price Associates

Top funds holding Definium Therape

BlackRock
venBio Select Advisor
Driehaus Capital Management
Jupiter Topco
FMR
Geode Capital Management
Henderson Group
Capital Research and Management Company - Division 3
Octagon Capital Advisors
Wellington Management Company
Deep Track Capital
State Street Corporation
Citadel Advisors
Commodore Capital
Susquehanna International

View all funds holding Definium Therape